Live: onsemi Q1 Earnings Tonight. Can the Stock Continue Its 90% YTD Rally?

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Oct 1, 2018 at 10:25 AM EDT

Why Akorn Shares Were Halved

Akorn shares were crushed early on Monday after a Delaware judge ruled that German health care group Fresenius could walk…

Chris Lange | Sep 29, 2018 at 8:15 AM EDT

Major Biopharma Catalysts on October’s FDA Calendar

Here is a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month…

Chris Lange | Sep 28, 2018 at 10:55 AM EDT

Equillium Prepares for IPO

Biotechnology company Equillium has amended its filing with the SEC regarding its initial public offering.

Jon C. Ogg | Sep 27, 2018 at 1:10 PM EDT

Why Aldeyra Could Have Another 100% Upside, or More

Two research firms have called for major upside ahead Aldeyra Therapeutics, even after the big pop in the stock on…

Chris Lange | Sep 27, 2018 at 11:10 AM EDT

US DEA Updates Schedule of Cannabidiol for GW Pharmaceuticals

GW Pharmaceuticals shares made a solid gain on Thursday after it received a critical update from the DEA.

Chris Lange | Sep 27, 2018 at 10:15 AM EDT

Protagonist Therapeutics Wins FDA Fast Track

Protagonist Therapeutics shares made a solid gain on Thursday after the company announced a key update from the FDA.

Chris Lange | Sep 27, 2018 at 9:45 AM EDT

Why Geron Is Getting Crushed

Geron shares were absolutely crushed on Thursday morning after it was announced that Janssen Biotech has terminated the 2014 collaboration…

Lee Jackson | Sep 27, 2018 at 8:35 AM EDT

Merrill Lynch Loves Large Cap Biotech: 4 Top Stocks to Buy Now

Merrill Lynch recently highlighted sectors it considers a good opportunity now that are likely to outperform in the near term,…

Chris Lange | Sep 26, 2018 at 11:20 AM EDT

Verastem’s Copiktra Breaks Into China With New Licensing Deal

Verastem shares saw a handy gain on Wednesday after the company set an exclusive licensing agreement to develop and commercialize…

Chris Lange | Sep 26, 2018 at 8:50 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Sep 26, 2018 at 8:15 AM EDT

Major Biotechs Have Short Sellers on the Run

The September 14 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Sep 24, 2018 at 12:50 PM EDT

Akcea and Ionis Pharma Win Big in Midstage Cardiovascular Disease Study

Akcea and Ionis Pharmaceuticals shares made a solid gain on Monday after the companies announced positive top-line data for a…

Chris Lange | Sep 24, 2018 at 12:10 PM EDT

Kodiak Sciences Announces Potential Pricing for IPO

Clinical-stage biopharmaceutical company Kodiak Sciences expects to price 9 million shares for an initial public company valued up to more…

Jon C. Ogg | Sep 24, 2018 at 10:45 AM EDT

What It Means for Gilead to Launch Its Own Generics for Hepatitis C Treatments

There is one fairly new effort for drug companies to mitigate the threat of generic drugs and for biotech companies…

Lee Jackson | Sep 24, 2018 at 10:25 AM EDT

Jefferies Biotech Growth Picks Have Big Upside Potential

Jefferies highlights the firm's top growth stocks to buy each week, and recently four top biotech stocks made the cut.…

1 … 118 119 120 121 122 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why Akorn Shares Were Halved

Major Biopharma Catalysts on October’s FDA Calendar

Equillium Prepares for IPO

Why Aldeyra Could Have Another 100% Upside, or More

US DEA Updates Schedule of Cannabidiol for GW Pharmaceuticals

Protagonist Therapeutics Wins FDA Fast Track

Why Geron Is Getting Crushed

Merrill Lynch Loves Large Cap Biotech: 4 Top Stocks to Buy Now

Verastem’s Copiktra Breaks Into China With New Licensing Deal

Short Sellers Grow More Selective on Major Pharma Stocks

Major Biotechs Have Short Sellers on the Run

Akcea and Ionis Pharma Win Big in Midstage Cardiovascular Disease Study

Kodiak Sciences Announces Potential Pricing for IPO

What It Means for Gilead to Launch Its Own Generics for Hepatitis C Treatments

Jefferies Biotech Growth Picks Have Big Upside Potential

Live: onsemi Q1 Earnings Tonight. Can the Stock Continue Its 90% YTD Rally?

Live: Will Palantir Beat Q1 Earnings Tonight After Market Close?

KLA Is Gaining Share as AI Chip Complexity Drives Up Yield Costs

Magna Stock Craters 10% as Strong Q1 Fails to Lift Full-Year Outlook

Broadcom, Qualcomm, or TSMC: Why One AI Chip Stock Won Decisively in April

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

KLA Is Gaining Share as AI Chip Complexity Drives Up Yield Costs

Magna Stock Craters 10% as Strong Q1 Fails to Lift Full-Year Outlook

Health and Healthcare Articles

All Health and Healthcare Articles

Why Akorn Shares Were Halved

Major Biopharma Catalysts on October’s FDA Calendar

Equillium Prepares for IPO

Why Aldeyra Could Have Another 100% Upside, or More

US DEA Updates Schedule of Cannabidiol for GW Pharmaceuticals

Protagonist Therapeutics Wins FDA Fast Track

Why Geron Is Getting Crushed

Merrill Lynch Loves Large Cap Biotech: 4 Top Stocks to Buy Now

Verastem’s Copiktra Breaks Into China With New Licensing Deal

Short Sellers Grow More Selective on Major Pharma Stocks

Major Biotechs Have Short Sellers on the Run

Akcea and Ionis Pharma Win Big in Midstage Cardiovascular Disease Study

Kodiak Sciences Announces Potential Pricing for IPO

What It Means for Gilead to Launch Its Own Generics for Hepatitis C Treatments

Jefferies Biotech Growth Picks Have Big Upside Potential

Live: onsemi Q1 Earnings Tonight. Can the Stock Continue Its 90% YTD Rally?

Live: Will Palantir Beat Q1 Earnings Tonight After Market Close?

KLA Is Gaining Share as AI Chip Complexity Drives Up Yield Costs

Magna Stock Craters 10% as Strong Q1 Fails to Lift Full-Year Outlook

Broadcom, Qualcomm, or TSMC: Why One AI Chip Stock Won Decisively in April

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how